Depression in Alzheimer's Disease-2

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2009

Conditions
Alzheimer's DiseaseDepression
Interventions
DRUG

Sertraline (Zoloft)

Sertraline: range of 25 to 125 mg per day for 24 weeks

DRUG

Placebo

Placebo designed to mimic sertraline taken daily for 24 weeks

Trial Locations (5)

14620

University of Rochester, Rochester

19104

University of Pennsylvania, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

29406

Medical University of South Carolina, North Charleston

90033

University of Southern California, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Johns Hopkins University

OTHER

NCT00086138 - Depression in Alzheimer's Disease-2 | Biotech Hunter | Biotech Hunter